Khattar Jack A. Insider Trades

Insider Trading History

Track insider trading activity for Khattar Jack A.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
President, CEO
Holding Value $42.7M 968,962 shares
Last Trade
Mar 13, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.76M 35,000 shares
$50.37
$44.04
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
President, CEO
Holding Value $43.7M 993,100 shares
Last Trade
Mar 13, 2026 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$624k 12,500 shares
$49.91
$44.04
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
President, CEO
Holding Value $54.7M 1,241,144 shares
Last Trade
Mar 13, 2026 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$624k 12,500 shares
$49.91
$44.04
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
President, CEO
Holding Value $54.8M 1,245,218 shares
Last Trade
Mar 06, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.08M 38,640 shares
$53.87
$44.04
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
President, CEO
Holding Value $0 0 shares
Last Trade
Mar 06, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.08M 38,640 shares
$53.87
$44.04
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
President, CEO
Holding Value $54.1M 1,228,644 shares
Last Trade
Mar 06, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$907k 16,574 shares
$54.73
$44.04
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
President, CEO
Holding Value $1.7M 38,640 shares
Last Trade
Feb 28, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.11M 38,640 shares
$54.73
$44.04
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
President, CEO
Holding Value $15M 341,610 shares
Last Trade
Feb 18, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$17.1M 341,610 shares
$50.20
$44.04
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
President, CEO
Holding Value $55.8M 1,266,478 shares
Last Trade
Oct 09, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$4.02M 81,250 shares
$49.51
$44.04
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
President, CEO
Holding Value $53.2M 1,208,107 shares
Last Trade
Oct 09, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.03M 59,900 shares
$50.57
$44.04
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
President, CEO
Holding Value $0 0 shares
Last Trade
Oct 09, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$4.02M 81,250 shares
$49.51
$44.04
scPharmaceuticals
scPharmaceuticals SCPH
Director
Holding Value $0 0 shares
Last Trade
Oct 07, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$409k 72,174 shares
$5.67
$5.67
scPharmaceuticals
scPharmaceuticals SCPH
Director
Holding Value $0 0 shares
Last Trade
Oct 07, 2025 Sale (Tender)Reported as Tender on SEC Form 4.
$28.4k 5,000 shares
$5.67
$5.67
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
President, CEO
Holding Value $52.5M 1,192,757 shares
Last Trade
Oct 02, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$109k 2,267 shares
$47.96
$44.04
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
President, CEO
Holding Value $52.2M 1,185,228 shares
Last Trade
Oct 02, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$708k 15,325 shares
$46.21
$44.04
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
President, CEO
Holding Value $0 0 shares
Last Trade
Oct 02, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$109k 2,267 shares
$47.96
$44.04
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
President, CEO
Holding Value $51.1M 1,161,233 shares
Last Trade
Oct 02, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$91.5k 1,904 shares
$48.06
$44.04
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
President, CEO
Holding Value $52.9M 1,201,043 shares
Last Trade
Oct 01, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.58M 53,785 shares
$48.04
$44.04
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
President, CEO
Holding Value $51.1M 1,160,870 shares
Last Trade
Oct 01, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.93M 40,173 shares
$48.07
$44.04
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
President, CEO
Holding Value $3.68M 83,517 shares
Last Trade
Oct 01, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.58M 53,785 shares
$48.04
$44.04

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up